Interesting, thanks Minister. Can't get the full article but note the study is from Spain. European guidelines for arthritis management
recommend prescription CS as part of Step 1 background treatment. High-grade, quality-controlled, prescription CS is available in Europe.
https://pubmed.ncbi.nlm.nih.gov/31126594/CS is not available by prescription in North America. It's sold over the counter and quality is unreliable. No one certifies it. The North American guidelines for arthritis management therefore do
not recommend the taking of CS as numerous studies have failed to prove effectiveness. I tried a 2-month course for the heck of it - made no difference. I do not believe I have synovitis, though. I am based in Canada.
https://pubmed.ncbi.nlm.nih.gov/31278997/The two links I've provided may not give you the full text either but with some creative googling one should be able to get it - for the European and North American arthritis guidelines. I have them. Maybe try the sites of OARSI and ESCEO.
I have attached a summary diagram of the current (2019) European guidelines. This is the accepted mainstream and is periodically updated as new research builds up. Step 4 is brutal if TKR is contra-indicated.